Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/3/18 → 8/6/19 |
Funding
- Finch Research and Development LLC: $8,997.00
PRISM-EXT: An Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota# (CP101) in Subjects with Recurrence of Clostridium difficile Infection
- Greenberg, Richard (PI)